Research summary ·
Association Between Isolated Maternal Hypothyroxinemia and Adverse Maternal and Infant Outcomes.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study looked at a thyroid problem in pregnancy. It is called isolated maternal hypothyroxinemia, or IMH. The team pooled results from earlier studies in a meta-analysis. They searched large research databases up to November 15, 2024. They asked how common IMH was. They also asked if IMH was linked to problems in pregnancy and birth.
What they found
The review used 22 cohort studies. In these studies, 16 390 women had IMH. The abstract gives a figure for how common IMH was. Women with IMH were compared with women with normal thyroid function. Those with IMH more often had diabetes in pregnancy, called GDM. They also had more babies born early. Babies born large, called macrosomia, were also more common. Preeclampsia and eclampsia were more common too.
What it means for patients
The authors say IMH is linked to a higher risk of several problems. These are GDM, preeclampsia, eclampsia, early birth and macrosomia. The risk is compared with pregnant women whose thyroid works normally. The authors expect future studies to further confirm these links.
Why it is not certain yet
The abstract does not say if treating IMH changes these risks. The team used a tool to check study quality. But the abstract does not report what that check found. A review can only be as good as the studies in it.
Source
Association Between Isolated Maternal Hypothyroxinemia and Adverse Maternal and Infant Outcomes.
PubMed · PMID 42706499We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Hypothyroidism publications